The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mizuno, M.
Right arrow Articles by Okada, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mizuno, M.
Right arrow Articles by Okada, H.
The Journal of Immunology, 1999, 162: 5477-5482.
Copyright © 1999 by The American Association of Immunologists

Inhibition of a Membrane Complement Regulatory Protein by a Monoclonal Antibody Induces Acute Lethal Shock in Rats Primed with Lipopolysaccharide1

Masashi Mizuno*, Kazuhiro Nishikawa*, Noriko Okada{dagger}, Seiichi Matsuo*, Kenichi Ito* and Hidechika Okada2,{dagger}

* Third Department of Internal Medicine, Nagoya University School of Medicine, Nagoya, Japan; and {dagger} Department of Molecular Biology, Nagoya City University School of Medicine, Nagoya, Japan

Rats pretreated with traces of LPS developed acute fatal shock syndrome after i.v. administration of a mAb that inhibits the function of a membrane complement regulatory molecule. Such a shock was not observed after the administration of large amounts of LPS instead of the mAb following LPS pretreatment. The lethal response did not occur in rats depleted of either leukocytes or complement, and a C5a receptor antagonist was found to inhibit the reaction. Furthermore, LPS-treated rats did not suffer fatal shock following the injection of cobra venom factor, which activates complement in the fluid phase so extensively as to exhaust complement capacity. Therefore, complement activation on cell membranes is a requirement for this type of acute reaction.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Asai, T. Sato, T. Tada, T. Miyamoto, N. Kimbara, N. Motoyama, H. Okada, and N. Okada
Absence of Procarboxypeptidase R Induces Complement-Mediated Lethal Inflammation in Lipopolysaccharide-Primed Mice
J. Immunol., October 1, 2004; 173(7): 4669 - 4674.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Fujita, I. Farkas, W. Campbell, L. Baranyi, H. Okada, and N. Okada
Inactivation of C5a Anaphylatoxin by a Peptide That Is Complementary to a Region of C5a
J. Immunol., May 15, 2004; 172(10): 6382 - 6387.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. J. Strachan, T. M. Woodruff, G. Haaima, D. P. Fairlie, and S. M. Taylor
A New Small Molecule C5a Receptor Antagonist Inhibits the Reverse-Passive Arthus Reaction and Endotoxic Shock in Rats
J. Immunol., June 15, 2000; 164(12): 6560 - 6565.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.